Jane Street Group, LLC Axonics, Inc. Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

A detailed history of Jane Street Group, LLC transactions in Axonics, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 30,545 shares of AXNX stock, worth $2.17 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

30,545

Previous 50,966 40.07%

Holding current value

$2.17 Million

Previous $3.43 Million 37.89%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$67.3 - $69.67 $1.37 Million - $1.42 Million	-20,421 Reduced 40.07%	30,545 $2.13 Million
Q2 2024 Aug 14, 2024	BUY	$66.47 - $69.65 $2 Million - $2.09 Million	30,020 Added 143.32%	50,966 $3.43 Million
Q1 2024 May 15, 2024	SELL	$56.67 - $69.36 $873,624 - $1.07 Million	-15,416 Reduced 42.4%	20,946 $1.44 Million
Q4 2023 Feb 14, 2024	BUY	$49.38 - $63.75 $301,069 - $388,683	6,097 Added 20.15%	36,362 $2.26 Million
Q3 2023 Nov 14, 2023	BUY	$48.64 - $62.51 $448,314 - $576,154	9,217 Added 43.79%	30,265 $1.7 Million
Q2 2023 Aug 14, 2023	SELL	$47.99 - $60.21 $818,709 - $1.03 Million	-17,060 Reduced 44.77%	21,048 $1.06 Million
Q1 2023 May 15, 2023	BUY	$52.6 - $67.34 $1.29 Million - $1.65 Million	24,545 Added 180.97%	38,108 $2.08 Million
Q4 2022 Feb 14, 2023	SELL	$59.56 - $76.6 $407,986 - $524,710	-6,850 Reduced 33.56%	13,563 $848,000
Q3 2022 Nov 14, 2022	SELL	$57.96 - $78.12 $2.72 Million - $3.67 Million	-46,999 Reduced 69.72%	20,413 $1.44 Million
Q2 2022 Aug 16, 2022	BUY	$39.5 - $64.42 $1.39 Million - $2.27 Million	35,209 Added 109.33%	67,412 $3.82 Million
Q1 2022 May 17, 2022	BUY	$43.74 - $62.76 $1.21 Million - $1.73 Million	27,578 Added 596.28%	32,203 $2.02 Million
Q4 2021 Feb 15, 2022	SELL	$50.01 - $73.35 $639,077 - $937,339	-12,779 Reduced 73.43%	4,625 $259,000
Q3 2021 Nov 16, 2021	BUY	$59.21 - $78.66 $254,958 - $338,709	4,306 Added 32.88%	17,404 $1.13 Million
Q2 2021 Aug 16, 2021	SELL	$51.39 - $66.9 $269,078 - $350,288	-5,236 Reduced 28.56%	13,098 $831,000
Q1 2021 May 18, 2021	BUY	$49.14 - $59.89 $404,471 - $492,954	8,231 Added 81.47%	18,334 $1.1 Million
Q4 2020 Feb 17, 2021	BUY	$42.19 - $51.5 $126,105 - $153,933	2,989 Added 42.02%	10,103 $504,000
Q3 2020 Nov 17, 2020	BUY	$35.33 - $51.04 $39,145 - $56,552	1,108 Added 18.45%	7,114 $363,000
Q2 2020 Aug 17, 2020	SELL	$22.91 - $39.83 $42,841 - $74,482	-1,870 Reduced 23.74%	6,006 $211,000
Q1 2020 May 15, 2020	BUY	$16.44 - $37.73 $129,481 - $297,161	7,876 New	7,876 $200,000

Others Institutions Holding AXNX

# of Institutions

234

Shares Held

42.1M

Call Options Held

83.4K

Put Options Held

65.3K

View Full List

About Axonics, Inc.

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

More about AXNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Axonics, Inc. Transaction History